hydroxyurea has been researched along with osalmide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chen, X; Chen, Z; Hou, C; Lin, Q; Liu, X; Lou, M; Qiu, Y; Shao, J; Song, R; Wang, M; Xu, Z; Yang, C; Zhu, L; Zhu, W | 1 |
| Shao, J; Tang, Q; Wu, L; Xu, M; Yan, D; Yan, S | 1 |
3 other study(ies) available for hydroxyurea and osalmide
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; DNA Replication; DNA, Circular; DNA, Viral; Drug Resistance, Viral; Drug Synergism; Genome, Viral; Hepatitis B virus; Humans; Hydroxyurea; Lamivudine; Liver; Mice; Mutation; Ribonucleoside Diphosphate Reductase; Salicylanilides; Virus Replication | 2016 |
Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Deoxyribonucleosides; DNA Damage; Esophageal Neoplasms; Female; Gene Knockdown Techniques; Humans; Hydroxyurea; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Ribonucleoside Diphosphate Reductase; Salicylanilides | 2020 |